	US 11,857,579 B2
	Composition for promoting the secretion of FGF21
Tatsuya Ehara, Kanagawa (JP); Hirohisa Izumi, Kanagawa (JP); and Takashi Shimizu, Kanagawa (JP)
Assigned to Morinaga Milk Industry Co., Ltd., Tokyo (JP)
Appl. No. 16/980,692
Filed by MORINAGA MILK INDUSTRY CO., LTD., Tokyo (JP)
PCT Filed Mar. 23, 2018, PCT No. PCT/JP2018/011917 § 371(c)(1), (2) Date Sep. 14, 2020, PCT Pub. No. WO2019/180964, PCT Pub. Date Sep. 26, 2019.
Prior Publication US 2021/0008129 A1, Jan. 14, 2021
Int. Cl. A61K 35/745 (2015.01); A23L 33/135 (2016.01); A61K 31/7016 (2006.01); A61K 31/702 (2006.01)

CPC A61K 35/745 (2013.01) [A23L 33/135 (2016.08); A61K 31/702 (2013.01); A61K 31/7016 (2013.01); A23V 2400/519 (2023.08)]

7 Claims

1. A method for modulating palatability in a subject in need of said modulating, comprising administering a Bifidobacterium bacterium in an effective amount for modulating palatability to said subject,

wherein the Bifidobacterium bacterium is Bifidobacterium breve M-16V (NITE BP-02622),

wherein said modulating occurs via promotion of secretion of FGF21 in said subject, and

wherein modulating palatability is reducing the unbalanced types of diet, helping to take a wide variety of types of diet without faddiness, and adjusting the sense of taste.